DSIP 10mg

DSIP (Delta Sleep-Inducing Peptide) 10mg is a naturally occurring nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. DSIP was first isolated from rabbit cerebral venous blood in the 1970s and has a substantial research history in neuroscience.

The compound has been investigated in experimental contexts involving central nervous system peptide signalling, neuromodulatory pathway interactions and hypothalamic regulatory dynamics. Its endogenous origin and defined nine-residue sequence make it a useful reference compound for researchers studying peptide-mediated signalling.

As with other neurobiology research materials, experimental findings should be interpreted within the limits of the model and assay. Observations in a cellular or preclinical system do not automatically establish human effects.

The 10mg presentation is supplied for laboratory research. Researchers should review the current product specification and applicable COA before use and retain batch information within their experimental records.

Each batch is supplied with a Certificate of Analysis (COA) from independent third-party testing, covering HPLC purity and mass-spectrometry identity.

Researchers should follow approved laboratory procedures for storage, handling, preparation and disposal. DSIP 10mg is for laboratory research use only. It is not a medicinal product, is not licensed by the MHRA and is not intended for human or veterinary use, diagnosis, treatment or self-administration. Sold only to qualified researchers aged 18 or over.